^
Association details:
Biomarker:No biomarker
Cancer:Kaposi Sarcoma
Drug:paclitaxel (Bcl2 inhibitor, Tubulin polymerization promoter)
Direction:Sensitive
Evidence:
Evidence Level:
Sensitive: A2 - Guideline
Source:
Published date:
02/03/2022
Excerpt:
Kaposi Sarcoma...Other recommended regimen...Paclitaxel